The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial-Reference-Cited by-同舟云学术

The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial

Published:2021-03 Issue: Volume:36 Page:51-55
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Yamaguchi Takeshi^ORCID,Hozumi Yasuo,Sagara Yasuaki,Takahashi Masato,Yoneyama Kimiyasu,Fujisawa Tomomi,Osumi Shozo,Akabane Hiromitsu,Nishimura Reiki^ORCID,Mieno Makiko Naka,Mukai Hirofumi

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference16 articles.

1. Proto-oncogenes and human cancers;Slamon;N. Engl. J. Med.,1987

2. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer;Goldenberg;Clin. Therapeut.,1999

3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N. Engl. J. Med.,2001

4. Optimal systemic therapy for early breast cancer in women: a clinical practice guideline;Eisen;Curr. Oncol.,2015

5. Evolving concepts in the systemic adjuvant treatment of breast cancer;Bonadonna;Can. Res.,1992

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapies in Early-Stage Breast Cancer: Current Practices, Treatment De-escalation, and Future Prospects;Cureus;2024-02-29

2. Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis;Journal of Surgical Research;2024-01

3. Curative effect of immediate reconstruction after neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-11-23

4. A generalized non-linear model predicting efficacy of neoadjuvant therapy in HER2+ breast cancer;iScience;2023-04